secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0001641172-25-001060
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Impact Biomedical settles $8.7M debt with 2.4M shares at $3.60/share
--------------------------------------------------------------------

- Debt conversion with DSS Inc. settles $8,697,142.80 of the $13,176,477.03 principal balance.
- Issued 2,415,873 shares of common stock at $3.60 per share, equal to March 24 closing price.
- Original promissory note principal was $12,000,000; amended September 16, 2024.
- Settlement reduces outstanding debt by 66% while diluting existing shareholders by approximately 2.4M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000164117225001060/0001641172-25-001060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000164117225001060/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-001060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer